Mount Sinai School of Medicine

Site:	Mount Sinai School of Medicine
Address:
City:	New York
State:	NY
Zip:	10029
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer	Unknown	Active	Sunitinib + Radiation	NCT00463060
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Closed	Belzutifan	NCT04924075